Write a reviewFor vendors
♡
Home / Investors / Startups / Arrakis Therapeutics

Arrakis Therapeutics

Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
arrakistx.com ↗LinkedInX / Twitter

About Arrakis Therapeutics

Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of rSMs to treat a range of disease including neurology, oncology and rare genetic diseases, enabling physicians to offer enhanced care.

Industries

BioTechMedical DevicePharmaceuticals

Investors in Arrakis Therapeutics (5)

GV

Venture Fund · Mountain View, California · Founded 2009
Pre-SeedSeedSeries ASeries BFinTechHealthcareMedical DeviceProductivity Tools+70
971Investments
225Exits

HBM Healthcare Investments AG

Venture Fund · Zug, Switzerland · Founded 2001
Series CSeries DBioTechMedical DevicePharmaceuticalsHealthcare
219Investments
66Exits

Alexandria Venture Investments

Venture Fund · Pasadena, California · Founded 1996
BioTechMedical DevicePharmaceuticalsHealthcare+11
191Investments
34Exits

Pfizer

Corporate VC · New York · Founded 1849
BioTechMedical DevicePharmaceuticals
41Investments
17Exits

WuXi AppTec

Shanghai, China · Founded 2000
BioTechHealthcareArtificial Intelligence & Machine Learning (AI/ML)CloudTech+3
41Investments
7Exits